In the BioHarmony Drug Report Database
Benazepril
Lotensin (benazepril) is a small molecule pharmaceutical. Benazepril was first approved as Lotensin on 1991-06-25. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against angiotensin-converting enzyme.
Trade Name
|
Lotensin |
|---|---|
Common Name
|
benazepril |
ChEMBL ID
|
CHEMBL838 |
Indication
|
diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction |
Drug Class
|
Antihypertensives (ACE inhibitors) |
Image (chem structure or protein)